Targeted News Service

Queen Mary University of London: CtDNA-guided Adjuvant Therapy With Atezolizumab Improves Survival Outcomes in Patients With Muscle-invasive Bladder Cancer
October 20, 2025

LONDON, England, Oct. 20 -- Queen Mary University of London issued the following news:

* * *

CtDNA-guided adjuvant therapy with atezolizumab improves survival outcomes in patients with muscle-invasive bladder cancer

New findings from researchers at Queen Mary University of London, presented at the European Society for Medical Oncology (ESMO) Congress 2025, could improve survival for people with bladder cancer.

*

The pioneering stu . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form